BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28574279)

  • 1. Update on Immunohistochemical Analysis in Breast Lesions.
    Peng Y; Butt YM; Chen B; Zhang X; Tang P
    Arch Pathol Lab Med; 2017 Aug; 141(8):1033-1051. PubMed ID: 28574279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
    Kadivar M; Boozari B
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
    Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
    Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
    El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA
    Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
    Laurent E; Begueret H; Bonhomme B; Veillon R; Thumerel M; Velasco V; Brouste V; Hoppe S; Fournier M; Grellety T; MacGrogan G
    Am J Surg Pathol; 2019 Mar; 43(3):293-302. PubMed ID: 30628926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
    Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
    Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
    Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
    Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Immunohistochemistry With Thyroid Transcription Factor-1 for Pulmonary Adenocarcinoma.
    Konno H; Saito H; Nanjo H; Hiroshima Y; Kurihara N; Fujishima S; Atari M; Sato Y; Motoyama S; Nakamura R; Akagami Y; Minamiya Y
    Ann Thorac Surg; 2017 Aug; 104(2):471-476. PubMed ID: 28527968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of immunohistochemistry in breast pathology: a review and update.
    Liu H
    Arch Pathol Lab Med; 2014 Dec; 138(12):1629-42. PubMed ID: 25427042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
    Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
    Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Müllerian origin, and primary lung adenocarcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 May; 44(5):369-76. PubMed ID: 26875861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 Update.
    Tang P; Tse GM
    Arch Pathol Lab Med; 2016 Aug; 140(8):806-14. PubMed ID: 27472239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
    Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
    Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
    El Hag M; Schmidt L; Roh M; Michael CW
    Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
    Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
    J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.
    Rollins-Raval M; Chivukula M; Tseng GC; Jukic D; Dabbs DJ
    Arch Pathol Lab Med; 2011 Aug; 135(8):975-83. PubMed ID: 21809988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas.
    Davis DG; Siddiqui MT; Oprea-Ilies G; Stevens K; Osunkoya AO; Cohen C; Li XB
    Hum Pathol; 2016 Jan; 47(1):26-31. PubMed ID: 26527523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.